Australian Manufacturer Nailed for Process Validation and Testing Shortcomings

Drug Industry Daily
A A
The FDA hit Australian OTC drugmaker Jalco Cosmetics with a warning letter in a follow-up to a December inspection that revealed process validation and testing deficiencies at its facility in Silverwater, New South Wales.

To View This Article:

Login

Subscribe To Drug Industry Daily